Effectiveness, safety and feasibility of extended ‐release naltrexone for opioid dependence: a 9‐month follow‐up to a 3‐month randomized trial

Addiction, EarlyView.

Source: Addiction - June 23, 2018 Category: Addiction Authors: Kristin KlemmetsbySolli , Zill ‐e‐HumaLatif , ArildOpheim , PeterKrajci , KamniSharma‐Haase , Jūratė ŠaltytėBenth , LarsTanum , NikolajKunoe Source Type: research